NCT07563244 · RECRUITING

Computer-assisted Cognitive Stimulation Treatment for Delirium

This trial is testing whether adding a tablet-based cognitive stimulation program — think memory, attention, and orientation exercises delivered by an occupational therapist twice a day — helps hospitalized patients recover from delirium faster than standard non-drug care alone. It is a Phase NA behavioral study, meaning it is evaluating a care approach rather than a drug, and it has not yet established whether the intervention works. One week of treatment, then reassessment.

You may qualify if

  • All patients aged 60 years or over who are admitted to the subacute care center between 15 February and 15 October 2026 and who sign the informed consent (the patient and their family or legal guardians if the patient's cognitive condition prevents them from giving consent themselves)

You're excluded if

  • Patients who, at the time of admission, meet the criteria for palliative end-of-life care.
  • Individuals under 60 years of age, to ensure sample homogeneity and reduce confounding factors.
  • Individuals with severe visual or hearing impairment or aphasia, due to the difficulty of carrying out the cognitive intervention.
  • Serious communication difficulties due to language.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-05-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials